(PharmaNewsWire.Com, May 07, 2017 ) The report “Nucleic Acid Isolation and Purification Market by Product (Reagents, Kits, Instruments), Technology (Column-, Reagent-, Magnetic Bead-based), Application (Plasmid, Genomic DNA, miRNA, Total RNA, PCR Clean-up), & End Users - Global Forecast to 2020”, The report provides a detailed overview of the major drivers, restraints, and opportunities impacting the global Nucleic acid Isolation and Purification market along with the estimates and forecasts of the revenue and market share analysis.
Browse 80 market data tables and 94 figures spread through 169 pages and in-depth TOC on “Nucleic Acid Isolation and Purification Market by Product (Reagents, Kits, Instruments), Technology (Column-, Reagent-, Magnetic Bead-based), Application (Plasmid, Genomic DNA, miRNA, Total RNA, PCR Clean-up), & End Users - Global Forecast to 2020” <||>rnhttp://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.html Early buyers will receive 10% customization on reports. The nucleic acid isolation and purification market exhibits lucrative growth potential from 2015 to 2020. This market is driven by factors such as increasing automation and technological advancements, availability of benchtop instruments, and increasing investments from pharma companies. Download Report Brochure: - http://www.marketsandmarkets.com/pdfdownload.asp?id=229978287 Increasing healthcare expenditure will aid the growth of the nucleic acid isolation and purification market. Today, healthcare expenditure constitutes a significant part of the development budget of all countries. It consists of spending by both public and private sources on medical goods and services. Rapid economic development across the globe is expected to improve access to quality healthcare. Increasing healthcare expenditure will lead to a rise in the demand for quality healthcare and will be an important growth driver for the nucleic acid isolation and purification market. According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver in the nucleic acid isolation and purification market. The global nucleic acid isolation and purification market is segmented into products, technology, applications and end users. On the basis of product, the nucleic acid isolation and purification market is segmented into instruments, kits, and reagents. In 2015, the kits segment is expected to account for the largest share of the global nucleic acid isolation and purification market due to their low cost and easy usage in applications such as gene sequencing, molecular diagnostics, and gene cloning. On the basis of technology, the nucleic acid isolation and purification market is segmented into column-based isolation and purification, reagent-based isolation and purification, magnetic bead-based isolation and purification, and other technologies. In 2015, the column-based isolation and purification segment is expected to account for the largest share of the global nucleic acid isolation and purification market. The technology is cost-effective, simpler, and faster when compared to organic extraction, and can also be automated. Submit here for Speak to Analyst :- http://www.marketsandmarkets.com/speaktoanalyst.asp?id=229978287 On the basis of application, the nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, blood DNA isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR clean-up and other applications. In 2015, the plasmid DNA isolation segment is expected to account for the largest share of the global market. Purified plasmid DNA is widely used in a variety of downstream applications such as PCR, sequencing, expression of proteins, gene therapy, and transfection. On the basis of end user, the nucleic acid isolation and purification market is segmented into academic and government research institutes, pharmaceutical and biotechnology companies, contract research organizations, hospitals and diagnostic centers, and other end users. In 2015, the academic and government research institutes segment is expected to account for the largest share of the global nucleic acid isolation and purification market. This large share is attributed to the increasing research activities and use of nucleic acid test in molecular diagnostics. On the basis of region, the nucleic acid isolation and purification market is segmented into Asia, Europe, North America, and the Rest of the World (RoW). In 2015, North America is expected to command the largest share of the global nucleic acid isolation and purification market. The major players in the nucleic acid isolation and purification market include QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Co. LLC (U.S.), Agilent Technologies Inc. (U.S.), Illumina, Inc. (U.S.), Takara Bio, Inc. (Japan), Promega Corporation (U.S.), General Electric Company (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), and Bio-Rad Laboratories (U.S.). About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
